definiens: shall mean any rights Controlled by [COMPANY] to Develop, offer for sale and sell IGF - I and / o r IGF - I combined with BP3, outside of the US ; provided, how ever, that Ex - US Rights shall exclude any rights wi th respect to the Excluded Indications, any rights rel ating to GH, any rights granted to, or otherwise Co ntrolled by, any Third Party prior to the Effective Date, to the extent such rights are then still Controlled by th at Third Party and, if TM has notified [COMPANY] that it is no longer in terested in licensing rights under the BP3 Patents, any rights under the BP3 Patents . In addition, the Ex - US Agree ment shall provide for a non - exclusive right under any patents or other rights Controlled by [COMPANY] to Manufa cture, have made, use, export and import IGF - I and/ or IGF - I combined with BP3 outside of the US . TM may exerc ise its option under this Section F.1(a ) 1 ) with re spect to IGF - I alone or 2 ) with respect to IGF - I alone and w ith respect to IGF - I combined with BP3, but TM may not exercise its option under this Section F.1(a ) with respect to IGF - I combined with BP3 without exercisi ng its option with respect to IGF - I alone . For purposes of this Section F.6, shall mean, with respect to any Ex - US Rights, that one ( 1 ) year period commenci ng on the date on which [COMPANY] notifies TM of such Ex- US Rights in accordance with this Section F.6(a )